Aplagon Oy
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.aplagon.com
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
Early Phase 1
Recruiting
- Conditions
- Peripheral Arterial Occlusive DiseaseCritical Limb Ischemia
- Interventions
- Radiation: PET/CT scan
- First Posted Date
- 2024-01-12
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Aplagon Oy
- Target Recruit Count
- 10
- Registration Number
- NCT06204237
- Locations
- 🇳🇱
The University Medical Center Groningen, Groningen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath